Clinical Pancreatology for Practising Gastroenterologists and Surgeons. Группа авторов
Pancreas in Cystic Fibrosis and CFTR‐related Disorders Pathogenesis of CFTR‐related Pancreatitis Pancreatic cystosis CFTR‐modifying Therapies Conclusion References 48 Nutritional Therapy, Pancreatic Exocrine Insufficiency, and Pancreatic Enzyme Replacement Therapy in Cystic Fibrosis Introduction Mechanisms of Pancreatic Exocrine Insufficiency Diagnosis of Pancreatic Exocrine Insufficiency Nutritional Consequences and Treatment of Pancreatic Exocrine Insufficiency Follow‐up Care of Patients with Pancreatic Exocrine Insufficiency Future of CF Nutrition Care References
12
Section V: Pancreatic Cancer
49 Epidemiological Impact of Pancreatic Cancer
Current Burden of Pancreatic Cancer
Time Trends
Risk Factors for Pancreatic Cancer
Attributable Fraction of Pancreatic Cancer due to Potentially Modifiable Risk Factors
Future Burden of Pancreatic Cancer
Conclusion
References
50 Molecular and Genetic Basis of Pancreatic Carcinogenesis
Introduction
Individual Therapy Based on the Genomic and Transcriptomic Traits of Pancreatic Cancer
Organoids for Response Prediction
Enhancing the Activation of Immune Surveillance and Inhibition of Immune Suppression
Exploiting the Metabolic Alterations in Pancreatic Cancer Cells
Targeting the Tumor Stroma
Summary
References
51 New‐onset Diabetes as a Harbinger of Pancreatic Cancer: is Early Diagnosis Possible?
Introduction
Epidemiology of DM in PDAC
Using NOD for Early Detection of PDAC
Methods to Enrich the NOD Cohort to Screen for PDAC
Current Research Endeavors
Conclusions and Recommendations to Practitioners
Acknowledgments
References
52 Pancreatic Cancer Screening
Introduction
Target Populations
Screening Modality
Screening Protocol
Outcomes of Screening and Surveillance Programs
Cost‐effectiveness of Pancreatic Cancer Screening Programs
Conclusion
Acknowledgments
References
53 Clinical Usefulness of Biological Markers in Pancreatic Cancer
Introduction
Challenges in Early Detection of Pancreatic Cancer
Role of Clinically Established Biomarkers of Pancreatic Cancer
Early Cancer Detection by Novel Biomarkers
Summary
References
54 Staging Classification and Stratification of Pancreatic Cancer for Clinical Practice
Introduction
Clinical Staging
Clinically Relevant Molecular Features
Imaging Classification of Non‐metastatic Disease
Imaging for Staging
Evaluating Response to Neoadjuvant Therapy
Future Directions
Acknowledgments
References
55 Imaging Diagnosis and Staging of Pancreatic Cancer
Introduction
CT Technique
Anatomy
Pancreatic Adenocarcinoma
Conclusion
References
56